Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Lobaric Acid Inhibits VCAM-1 Expression in TNF-α-Stimulated Vascular Smooth Muscle Cells via Modulation of NF-κB and MAPK Signaling Pathways

  • Received : 2015.01.25
  • Accepted : 2015.09.24
  • Published : 2016.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Lichens have been known to possess multiple biological activities, including anti-proliferative and anti-inflammatory activities. Vascular cell adhesion molecule-1 (VCAM-1) may play a role in the development of atherosclerosis. Hence, VCAM-1 is a possible therapeutic target in the treatment of the inflammatory disease. However, the effect of lobaric acid on VCAM-1 has not yet been investigated and characterized. For this study, we examined the effect of lobaric acid on the inhibition of VCAM-1 in tumor necrosis factor-alpha (TNF-${\alpha}$)-stimulated mouse vascular smooth muscle cells. Western blot and ELISA showed that the increased expression of VCAM-1 by TNF-${\alpha}$ was significantly suppressed by the pre-treatment of lobaric acid ($0.1-10{\mu}g/ml$) for 2 h. Lobaric acid abrogated TNF-${\alpha}$-induced NF-${\kappa}B$ activity through preventing the degradation of $I{\kappa}B$ and phosphorylation of extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinases (JNK), and p38 mitogen activated protein (MAP) kinase. Lobaric acid also inhibited the expression of TNF-${\alpha}$ receptor 1 (TNF-R1). Overall, our results suggest that lobaric acid inhibited VCAM-1 expression through the inhibition of p38, ERK, JNK and NF-${\kappa}B$ signaling pathways, and downregulation of TNF-R1 expression. Therefore, it is implicated that lobaric acid may suppress inflammation by altering the physiology of the atherosclerotic lesion.

Keywords

References

  1. Angel, P. and Karin, M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157.
  2. Armitage, R. J. (1994) Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin Immunol. 6, 407-413. https://doi.org/10.1016/0952-7915(94)90119-8
  3. Beg, A. A., Finco, T. S., Nantermet, P. V. and Baldwin, AS. Jr. (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell Biol. 13, 3301-3310. https://doi.org/10.1128/MCB.13.6.3301
  4. Braun, M., Pietsch, P., Schrör, K., Baumann, G. and Felix, SB. (1999) Cellular adhesion molecules on vascular smooth muscle cells. Cardiovasc. Res. 41, 395-401. https://doi.org/10.1016/S0008-6363(98)00302-2
  5. Chalmers, J. A., Martino, T. A., Tata, N., Ralph, M. R., Sole, M. J. and Belsham, D. D. (2008) Vascular circadian rhythms in a mouse vascular smooth muscle cell line (MOVAS-1). Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1529-1538. https://doi.org/10.1152/ajpregu.90572.2008
  6. Cho, S. J., Kang, N. S., Park, S. Y., Kim, B. O., Rhee, D. K. and Pyo, S. (2003) Induction of apoptosis and expression of apoptosis related genes in human epithelial carcinoma cells by Helicobacter pylori VacA toxin. Toxicon 42, 601-611. https://doi.org/10.1016/j.toxicon.2003.08.003
  7. Choi, K. W., Park, H. J., Jung, D. H., Kim, T.W., Park, Y. M., Kim, B. O., Sohn, E. H., Moon, E. Y., Um, S. H., Rhee, D. K. and Pyo, S. (2010) Inhibition of TNF-${\alpha}$-induced adhesion molecule expression by diosgenin in mouse vascular smooth muscle cells via downregulation of the MAPK, Akt and NF-${\kappa}$B signaling pathways. Vascul. Pharmacol. 53, 273-280. https://doi.org/10.1016/j.vph.2010.09.007
  8. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D. and Maniatis, T. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9, 899-909. https://doi.org/10.1096/fasebj.9.10.7542214
  9. Falk, E. (2006) Pathogenesis of atherosclerosis. J. Am. Coll. Cardiol. 47, C7-12. https://doi.org/10.1016/j.jacc.2005.09.068
  10. Gissurarson, S. R., Sigurdsson, S. B., Wagner, H. and Ingolfsdottir, K. (1997) Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig taenia coli. J. Pharmacol. Exp. Ther. 280, 770-773.
  11. Hidalgo, M. E., Bascuñan, L., Quilhot, W., Fernández, E. and Rubio, C. (2005) Spectroscopic and photochemical properties of the lichen compound lobaric acid. Photochem. Photobiol. 81, 1447-1449. https://doi.org/10.1562/2005-05-17-RA-530
  12. Ho, A. W., Wong, C. K. and Lam, C. W. (2008) Tumor necrosis factoralpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways. Immunobiology 213, 533-544. https://doi.org/10.1016/j.imbio.2008.01.003
  13. Huo, Y. and Ley, K. (2001) Adhesion molecules and atherogenesis. Acta Physiol. Scand. 173, 35-43. https://doi.org/10.1046/j.1365-201X.2001.00882.x
  14. Ingolfsdottir, K., Gissurarson, S. R., Moller-Jakic, B., Breu, W. and Wagner, H. (1996) Inhibitory effects of the lichen metabolite lobaric acid on arachidonate metabolism in vitro. Phytomedicine 2, 243- 246. https://doi.org/10.1016/S0944-7113(96)80049-3
  15. Jang, Y., Lincoff, A. M., Plow, E. F. and Topol, E. J. (1994) Cell adhesion molecules in coronary artery disease. J. Am. Coll. Cardiol. 24, 1591-1601. https://doi.org/10.1016/0735-1097(94)90162-7
  16. Ju, J. W., Kim, S. J., Jun, C. D. and Chun, J. S. (2002) p38 kinase and c-Jun N-terminal kinase oppositely regulates tumor necrosis factor alpha-induced vascular cell adhesion molecule-1 expression and cell adhesion in chondrosarcoma cells. IUBMB Life 54, 293-299. https://doi.org/10.1080/15216540215674
  17. Kasper, H. U., Schmidt, A. and Roessner, A. (1996) Expression of the adhesion molecules ICAM, VCAM, and ELAM in the arteriosclerotic plaque. Gen. Diagn. Pathol. 141, 289-294.
  18. Kitagaki, M., Isoda, K., Kamada, H., Kobayashi, T., Tsunoda, S., Tsutsumi, Y., Niida, T., Kujiraoka, T., Ishigami, N., Ishihara, M., Matsubara, O., Ohsuzu, F. and Kikuchi, M. (2012) Novel TNF-${\alpha}$ receptor 1 antagonist treatment attenuates arterial inflammation and intimal hyperplasia in mice. J. Atheroscler. Thromb. 19, 36-46 https://doi.org/10.5551/jat.9746
  19. Ledebur, H. C. and Parks, T. P. (1995) Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J. Biol. Chem. 270, 933-943. https://doi.org/10.1074/jbc.270.2.933
  20. Lee, Y. W., Kim, P. H,. Lee, W. H. and Hirani, A. A. (2010) Interleukin-4, oxidative stress, vascular inflammation and atherosclerosis. Biomol. Ther. 18, 135-144. https://doi.org/10.4062/biomolther.2010.18.2.135
  21. Libby, P. and Li, H. (1993) Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J. Clin. Invest. 92, 538-539. https://doi.org/10.1172/JCI116620
  22. Lusis, A. J. (2000) Atherosclerosis. Nature 407, 233-241. https://doi.org/10.1038/35025203
  23. Mackay, F., Loetscher, H., Stueber, D., Gehr, G. and Lesslauer, W. (1993) Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177, 1277-1286. https://doi.org/10.1084/jem.177.5.1277
  24. Mackenzie, N. C., Zhu, D., Longley, L., Patterson, C. S., Kommareddy, S. and MacRae, V. E. (2011) MOVAS-1 cell line: a new in vitro model of vascular calcification. Int. J. Mol. Med. 27, 663-668.
  25. Mo, S. J., Son, E. W., Lee, S. R., Lee, S. M., Shin, D. H. and Pyo, S. (2007) CML-1 inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in endothelial cells through inhibition of IkBalpha kinase. J. Ethnopharmacol. 109, 78-86. https://doi.org/10.1016/j.jep.2006.07.006
  26. Morita, H., Tsuchiya, T., Kishibe, K., Noya, S., Shiro, M., Hirasawa, Y. (2009) Antimitotic activity of lobaric acid and a new benzofuran, sakisacaulon A from Stereocaulon sasakii. Bioorg Med Chem Lett. 19, 3679-3681. https://doi.org/10.1016/j.bmcl.2009.03.170
  27. Ogmundsdottir, H. M., Zoega, G. M., Gissurarson, S. R. and Ingolfsdottir, K. (1998) Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes. J. Pharm. Pharmacol. 50, 107-115.
  28. Ovstedal, D. O and Smith, R. L. (2001) Lichens of Antarctica and South Georgia. a guide to their identification and ecology. Cambridge University Press
  29. Owens, G. K., Kumar, M. S. and Wamhoff, B. R. (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801. https://doi.org/10.1152/physrev.00041.2003
  30. Pahl, H. L. (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866. https://doi.org/10.1038/sj.onc.1203239
  31. Sawa, Y., Sugimoto, Y., Ueki, T., Ishikawa, H., Sato, A., Nagato, T. and Yoshida, S. (2007) Effects of TNF-alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium. J. Histochem. Cytochem. 55, 721-733. https://doi.org/10.1369/jhc.6A7171.2007
  32. Thadhani, V. M., Naaz, Q., Choudhag, M. I., Mesaik, A. and Karunaratne, V. (2014) Enzyme inhibitory and immunomodulatory activities of the depsidone lobaric acid extracted from the lichen Heterodermia sp. J. Natn. Sci. Foundation Sri Lanka 42, 193-196. https://doi.org/10.4038/jnsfsr.v42i2.6988
  33. Waddick, K. G and Uckun, F. M. (1999) Innovative treatment programs against cancer: II. Nuclear factor-kappaB (NF-kappaB) as a molecular target. Biochem. Pharmacol. 57, 9-17. https://doi.org/10.1016/S0006-2952(98)00224-X
  34. Zhang, L., Peppel, K., Sivashanmugam, P., Orman, E. S., Brian, L., Exum, S. T. and Freedman, N. J. (2007) Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 1087-1094. https://doi.org/10.1161/01.ATV.0000261548.49790.63

Cited by

  1. Recent literature on lichens—242 vol.119, pp.3, 2016, https://doi.org/10.1639/0007-2745-119.3.316
  2. New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism vol.25, pp.5, 2017, https://doi.org/10.4062/biomolther.2016.271
  3. Hydroquinone suppresses IFN-β expression by targeting AKT/IRF3 pathway vol.21, pp.5, 2017, https://doi.org/10.4196/kjpp.2017.21.5.547
  4. A novel urotensin II receptor antagonist, KR-36676, prevents ABCA1 repression via ERK/IL-1β pathway vol.803, 2017, https://doi.org/10.1016/j.ejphar.2017.03.056
  5. Total Syntheses of Lobaric Acid and Its Derivatives from the Antarctic Lichen Stereocaulon alpinum vol.81, pp.6, 2018, https://doi.org/10.1021/acs.jnatprod.8b00227
  6. Sorghum Fermented by Aspergillus oryzae NK Enhances Inhibition of Vascular Inflammation in TNF-α-stimulated Human Aortic Smooth Muscle Cells vol.88, pp.5, 2016, https://doi.org/10.1024/0300-9831/a000496
  7. Melatonin Inhibits in Vitro Smooth Muscle Cell Inflammation and Proliferation and Atherosclerosis in Apolipoprotein E-Deficient Mice vol.67, pp.7, 2019, https://doi.org/10.1021/acs.jafc.8b06217
  8. Bergaptol from blossoms of Citrus aurantium L. var. amara Engl inhibits LPS-induced inflammatory responses and ox-LDL-induced lipid deposition vol.11, pp.6, 2016, https://doi.org/10.1039/c9fo00255c
  9. EphB4/ TNFR2/ERK/MAPK signaling pathway comprises a signaling axis to mediate the positive effect of TNF-α on osteogenic differentiation vol.21, pp.1, 2020, https://doi.org/10.1186/s12860-020-00273-2